CLINICAL TRIALS FOR COVID-19 TREATMENT - VIEW ON A PERIOD 2020-2022

Abstract

The purpose of the article is to provide an overview of the dynamics of clinical trials for the COVID-19 treatment. We have therefore created a database from the Register of Authorized Clinical Trials, Bulgarian Drug Agency and from the European Union Drug Regulating Authorities Clinical Trials Databases, European Medicines Agency. We studied all 27 clinical trials authorized for conduction in Bulgaria in the search of a COVID-19 treatment during the pandemic (2020-2022).
The results of the article reveal the share and impact of the Bulgarian trial sites in the search for treatment of COVID-19. The pandemic has fundamentally changed clinical trials themselves and diverted attention from diseases other than COVID-19. Competent authority databases include clinical trials with therapeutic areas of impact close to the coronavirus, the results of which would be a benefactor for the accelerated launch of COVID-19 treatment, which motivated us to overview all clinical trials during the pandemic.